Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.01 | uM | 9 | 156.25 | 71.09 | 135.00 | 119.50 | 1.1297 | 1.3535 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 156.25 | 71.09 | 72.00 | 119.50 | 0.6025 | 0.0171 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 156.25 | 71.09 | 100.00 | 119.50 | 0.8368 | 0.5768 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 118.00 | 119.50 | 0.9875 | 0.9666 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 138.00 | 119.50 | 1.1548 | 1.4236 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 156.25 | 71.09 | 93.00 | 119.50 | 0.7782 | 0.4312 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 156.25 | 71.09 | 77.00 | 119.50 | 0.6444 | 0.1125 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 157.00 | 119.50 | 1.3138 | 1.8789 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 94.00 | 119.50 | 0.7866 | 0.4518 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 156.25 | 71.09 | 42.00 | 119.50 | 0.3515 | -0.5046 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 103.00 | 119.50 | 0.8619 | 0.6402 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 115.00 | 119.50 | 0.9623 | 0.9001 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 145.00 | 119.50 | 1.2134 | 1.5890 |
| BT-20 | Lapatinib | 1 | uM | 9 | 156.25 | 71.09 | 90.00 | 119.50 | 0.7531 | 0.3700 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 108.00 | 119.50 | 0.9038 | 0.7474 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 239.00 | 312.00 | 0.7660 | 0.5405 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 312.50 | 153.73 | 311.00 | 312.00 | 0.9968 | 0.9937 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 259.00 | 312.00 | 0.8301 | 0.6667 |
| BT-20 | Linsitinib | 10 | uM | 9 | 312.50 | 153.73 | 254.00 | 312.00 | 0.8141 | 0.6352 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 312.50 | 153.73 | 209.00 | 312.00 | 0.6699 | 0.3509 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 357.00 | 312.00 | 1.1442 | 1.2821 |
| BT-20 | Erlotinib | 1 | uM | 9 | 312.50 | 153.73 | 368.00 | 312.00 | 1.1795 | 1.3509 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 312.50 | 153.73 | 343.00 | 312.00 | 1.0994 | 1.1944 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 382.00 | 312.00 | 1.2244 | 1.4385 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 312.50 | 153.73 | 412.00 | 312.00 | 1.3205 | 1.6258 |